McKesson Corp (MCK)

This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial results. These earnings calls are crucial events for investors, analysts, and the broader market, as they provide insights into corporate

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

Healthcare distributor and services company McKesson (NYSE:MCK) announced better-than-expected revenue in Q2 CY2025, with sales up 23.4% year on year to $97.83 billion. Its non-GAAP profit of $8.26 per share was 1.4% above analysts’ consensus estimates.

Check out these five stocks that are beating the market in 2025 and just announced dividend increases of between 10% and 15%.

McKesson Corp (NYSE:MCK) beat Q1 2026 revenue and EPS estimates, raising full-year guidance. Stock dipped slightly post-earnings amid high expectations.

U.S. stocks rebounded sharply on Wednesday, fully erasing last Friday's losses, as upbeat corporate earnings and renewed investor optimism outweighed concerns over escalating trade tensions.

Healthcare distributor and services company McKesson (NYSE:MCK) will be reporting results this Wednesday after market close. Here’s what investors should know.

McKesson Corp (MCK) shows strong growth fundamentals and a promising technical breakout setup, making it a potential growth stock pick with upside potential.

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

MCKESSON CORP (NYSE:MCK) offers strong growth in healthcare distribution with reasonable valuation and solid financial health, making it a candidate for growth-at-a-price investors.

MCKESSON CORP (NYSE:MCK) shows strong growth fundamentals and a bullish technical setup, making it a stock to watch. The company's solid financials and breakout potential suggest further upside.

The spice maker said it is implementing several initiatives to manage the higher costs from tariffs.

MCKESSON CORP (NYSE:MCK) meets Minervini’s Trend Template with strong technicals and high growth fundamentals, making it a stock to watch for momentum investors.

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.